Health Canada approved EDAP TMS's (Nasdaq: EDAP) Focal One HIFU device
to treat prostate cancer sending the stock price up 75 cents to $3.07.
EDAP's Focal One HIFU device approved
January 09, 2015 at 12:36 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|